Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Clinical trial NCT02520219 · UNKNOWN

Trial details

NCT number: NCT02520219
Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas

Start date: 2014-12-01
Primary completion: 2015-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.